NCT03503578View on ClinicalTrials.gov

EEG Studies of Sevoflurane-Induced General Anesthesia

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Anesthesia
Interventions
DRUG

Sevoflurane

Subjects will received sevoflurane for approximately 60 minutes.

DRUG

Ketamine

Subjects will received sevoflurane and ketamine for approximately 60 minutes.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03503578 - EEG Studies of Sevoflurane-Induced General Anesthesia | Biotech Hunter | Biotech Hunter